Neurogenesis 47 min read January 27, 2026

PHDP5 Research for Alzheimer Disease

PHDP5 is a synthetic peptide showing promise in reducing beta-amyloid and tau protein accumulation in Alzheimer's disease models.

PHDP5 Research for Alzheimer Disease

Introduction

Currently, there is no cure for Alzheimer’s disease, a progressive neurodegenerative condition that affects millions of people worldwide. However, treatments are available to help manage its symptoms, such as memory loss, confusion, and difficulties with thinking and reasoning. While these therapies do not stop the disease, some have shown promise in slowing its progression, offering hope for improving the quality of life for those affected.

Alzheimer’s is characterized by the abnormal accumulation of proteins in the brain, such as beta-amyloid plaques and tau tangles, which interfere with the transmission of nerve impulses and disrupt normal brain function. These proteins build ups damage and ultimately kill brain cells, leading to the cognitive and functional decline associated with the disease.

In a groundbreaking study, researchers tested a synthetic peptide on mice genetically engineered to develop Alzheimer’s-like symptoms. The findings were promising, showing that the treatment significantly reduced the buildup of these harmful proteins in the brain. Even more compelling, the peptide therapy appeared to restore key cognitive functions, such as memory and learning, which are typically impaired in Alzheimer’s patients.

This study written about below highlights the potential of innovative therapeutic approaches to target the root causes of Alzheimer’s, rather than just addressing its symptoms. While further research, including human trials, is necessary to validate these findings, this development represents a significant step forward in the quest for more effective treatments and, ultimately, a cure for Alzheimer’s disease.

The problem

As global life expectancy continues to rise, dementia has become an increasingly pressing public health challenge. The prevalence of dementia is projected to grow significantly, with studies estimating that over 150 million people worldwide could be affected by 2050. This staggering statistic underscores the urgent need for effective prevention and treatment strategies.

Alzheimer’s disease, the most common form of dementia, is characterized by a variety of debilitating symptoms, including memory loss, cognitive decline, and personality changes. These symptoms are widely believed to result from the accumulation of two key proteins in the brain: beta-amyloid (Aβ) and tau. Beta-amyloid forms sticky plaques between neurons, while tau creates tangles within neurons, disrupting their structure and function. Together, these protein abnormalities lead to widespread neuronal damage, brain shrinkage, and the hallmark symptoms of Alzheimer’s.

Current treatments for Alzheimer’s primarily focus on alleviating symptoms, such as cognitive deficits and behavioral changes, rather than addressing the underlying causes of the disease. However, recent advancements have introduced disease-modifying therapies that aim to directly target these pathological proteins. For example, aducanumab and lecanemab, two monoclonal antibody treatments, have shown promise in reducing Aβ plaques in the brain. These therapies mark a significant step forward in targeting the disease at its root.

Despite these advancements, the use of monoclonal antibody treatments has sparked debate within the medical community. While they offer the potential to slow disease progression, their benefits are tempered by notable risks. Common side effects include brain swelling and microhemorrhages, raising concerns about the overall safety and efficacy of these treatments. Some experts question whether the modest clinical improvements observed in patients justify the associated risks, particularly considering the complex, multifactorial nature of Alzheimer’s disease.

As the global burden of dementia continues to rise, ongoing research is essential to refine these treatments, explore alternative therapeutic targets, and better understand the mechanisms underlying Alzheimer’s. The goal is to develop safer, more effective interventions that can not only slow disease progression but also prevent its onset, offering hope to millions of individuals and families affected by this devastating condition.

The possible solution

A recent study has introduced a promising new approach to treating Alzheimer’s disease by targeting tau protein accumulation. Tau proteins, when abnormally modified, form neurofibrillary tangles that disrupt the passage of nerve impulses across synapses, the critical junctions where nerve cells communicate. These tangles are a hallmark of Alzheimer’s and contribute significantly to the cognitive and memory impairments associated with the disease.

In this research, scientists tested the effects of a synthetic peptide, PHDP5, on transgenic mice engineered to develop Alzheimer’s-like symptoms. The peptide was found to inhibit a specific biochemical pathway responsible for tau buildup, effectively preventing the formation of these neurofibrillary tangles. Remarkably, the treatment not only reduced tau accumulation but also reversed deficits in memory and learning in the mice, suggesting its potential to restore cognitive functions impaired by Alzheimer’s.

The findings, published in the journal Brain Research, represent a significant step forward in understanding and addressing the complex mechanisms underlying Alzheimer’s disease. Unlike existing treatments that primarily target beta-amyloid plaques, this study highlights the importance of tau as a therapeutic target. By focusing on tau, the researchers offer a complementary approach that could work alongside beta-amyloid-targeting therapies to provide a more comprehensive strategy for tackling the disease.

Dr. Stefania Forner, the Alzheimer’s Association director of medical and scientific relations, who was not involved in the study, emphasized the significance of the findings. “Using a mouse model of Alzheimer’s disease, this study sheds some light on a novel potential treatment pathway,” she stated, underscoring the innovative nature of this research.

The use of PHDP5 as a therapeutic agent offers several advantages over traditional approaches. Targeting tau tangles directly could address a broader range of Alzheimer’s symptoms, particularly in patients where beta-amyloid-targeting therapies have shown limited efficacy. Additionally, the peptide's ability to reverse memory and learning deficits provides hope for interventions that not only halt disease progression but also restore lost cognitive abilities.

Peptide reduces tau buildup in brain

The transmission of nerve impulses across synapses—the communication hubs between nerve cells—is a highly coordinated process that depends on two key components: dynamin and microtubules. These structures work in tandem to facilitate the recycling of vesicles, which are tiny sacs that store and release neurotransmitters. Neurotransmitters are essential chemicals that carry the nerve impulse from one neuron to another, ensuring seamless communication in the nervous system.

In healthy individuals, tau proteins play a critical role in stabilizing microtubules, which serve as the structural framework of nerve cells. This stability ensures that dynamin remains available to support vesicle recycling and maintain effective synaptic communication. However, in Alzheimer’s disease, tau proteins become dysfunctional. They detach from the microtubules, leading to their destabilization. This process also results in the removal of dynamin from nerve cells, disrupting the recycling of vesicles. Over time, the detached tau aggregates into tangles, a hallmark of Alzheimer’s disease, further impairing the transmission of nerve impulses and contributing to cognitive decline.

In earlier in vitro (laboratory-based) research, scientists explored the potential of a synthetic peptide, PHPD5, to counteract these damaging effects. The peptide was shown to release dynamin, making it available to support the recycling of vesicles and restore communication between synapses. By targeting this critical pathway, PHPD5 effectively bypassed the disruption caused by tau dysfunction, offering a novel mechanism to preserve synaptic health.

Building on these promising in vitro findings, recent studies have expanded to animal models, where PHPD5 demonstrated the ability to reverse memory and learning deficits by addressing tau-related disruptions. By stabilizing microtubules and freeing dynamin for vesicle recycling, the peptide restores a fundamental aspect of neuronal function that is severely compromised in Alzheimer’s disease.

This research examines the complexity of Alzheimer’s pathology and highlights the need for multifaceted therapeutic approaches. While much of the focus in Alzheimer’s treatment has traditionally been on targeting beta-amyloid plaques, these findings reinforce the critical role of tau in disease progression. By addressing tau-induced disruptions in synaptic communication, PHPD5 offers a complementary strategy that could work synergistically with beta-amyloid-targeting therapies.

Future research will need to investigate the long-term safety and efficacy of PHPD5 in human clinical trials. Additionally, understanding how this peptide interacts with other cellular mechanisms in the brain could pave the way for even more refined treatments. If successful, PHPD5 and similar therapies could not only halt the progression of Alzheimer’s but also restore lost neuronal functions, offering hope for reversing some of the devastating effects of this disease.

Dr. Emer MacSweeney, CEO and Consultant Neuroradiologist at Re:Cognition Health, who was not involved in the study, told Medical News Today: “This research appears to be pioneering in specifically targeting the dynamin-microtubule interaction with the synthetic peptide PHDP5. While other treatments for Alzheimer’s focus on different mechanisms, such as amyloid-beta plaques and tau tangles, targeting the dynamin-microtubule pathway is relatively novel. The researchers have shown in vitro and in vivo evidence of the positive effects of inhibiting this interaction, suggesting this could be the first time it has been targeted in this manner.”

Peptide treatment reaches the brain

Building on earlier findings that demonstrated the efficacy of the synthetic peptide PHPD5 in in vitro studies, researchers advanced their investigation by testing the peptide in a living model. They used transgenic Tau609 mice, a widely recognized model for Alzheimer’s disease research. These mice develop hallmark features of the disease, including tau tangles, neuronal loss, and memory deficits, making them an ideal subject for evaluating the therapeutic potential of PHPD5.

Study Design and Administration

The researchers administered 2 mg of PHPD5 in saline solution intranasally once daily for four weeks. This method was chosen for its ability to deliver therapeutics directly to the brain, bypassing systemic metabolism and efficiently crossing the blood-brain barrier. As a control, another group of Tau609 mice received only the saline solution via the same delivery method.

Cognitive Testing Using the Morris Water Maze (MWM)

To assess the impact of the treatment on memory and learning, the researchers employed the Morris Water Maze (MWM) test, a gold standard for evaluating spatial memory in animal studies. After three weeks of treatment, the mice underwent four training sessions in a circular water trough, 100 cm in diameter and 30 cm deep. The objective was for the mice to locate an escape platform submerged in one quadrant of the trough. This training phase was designed to test their ability to learn and remember the platform’s location.

Following the training sessions, the researchers conducted a memory test in the same water trough, but this time without the escape platform. They measured how much time the mice spent in the quadrant where the platform had been previously located. This provided a clear indication of the mice's ability to recall the platform’s location, reflecting their spatial memory.

Results and Brain Analysis

After the behavioral testing, the mice were euthanized, and their brains were examined to evaluate the physiological effects of PHPD5. Notably, the researchers found that the peptide successfully crossed the blood-brain barrier and accumulated in the hippocampus, the brain region critical for learning and memory. This finding is significant, as the hippocampus is particularly vulnerable to damage in Alzheimer’s disease, and effective therapeutic delivery to this region is a critical hurdle in neurodegenerative research.

Implications and Future Directions

The results of this study are highly encouraging. The successful delivery of PHPD5 to the hippocampus and its potential to restore learning and memory in Tau609 mice suggest that this peptide could offer a novel therapeutic avenue for treating Alzheimer’s disease and other tau-related neurodegenerative conditions. The intranasal administration route is particularly noteworthy, as it provides a non-invasive and efficient method of drug delivery to the brain. Future research will need to address several key questions. While the results in mice are promising, human trials are necessary to confirm the peptide’s safety, efficacy, and long-term effects. Additionally, researchers must explore the mechanisms by which PHPD5 interacts with tau pathology, as well as its potential impacts on other brain regions affected by Alzheimer’s disease.

If these findings translate to human patients, PHPD5 could represent a groundbreaking advancement in Alzheimer’s treatment—offering hope for not only slowing disease progression but also reversing some of its cognitive and neurological damage. This study exemplifies the importance of innovative research in tackling the complexities of neurodegenerative diseases.

Improvements in learning and memory

The researchers evaluated the effects of PHPD5 treatment on learning and memory by comparing the performance of three groups of mice in the Morris Water Maze (MWM): wild-type (WT) mice, untreated control Tau609 mice, and PHPD5-treated Tau609 mice. This comparison provided a comprehensive assessment of the peptide's ability to restore cognitive functions impaired by tau pathology.

During the four-day training phase, the WT mice performed the best, demonstrating a 60% reduction in the time required to locate the hidden platform by the fourth session, reflecting their intact learning and memory capabilities. In contrast, the control Tau609 mice showed impaired learning, achieving only a 33% reduction in finding time over the same period, highlighting the cognitive deficits associated with tau accumulation. Remarkably, the PHPD5-treated Tau609 mice displayed significant improvements, with their performance closely mirroring that of the WT mice. By the fourth training session, the treated mice achieved a 55% reduction in the time needed to locate the platform, indicating substantial recovery of learning abilities.

On the fifth day, the researchers assessed memory retention by removing the platform and measuring how much time each group spent in the quadrant where the platform had been located. WT mice spent 36% of their time in the platform's previous location, demonstrating strong spatial memory retention. PHPD5-treated Tau609 mice spent 33% of their time in the same quadrant, showing near-normal memory recall comparable to the WT group. In contrast, control Tau609 mice spent only 25% of their time in the platform quadrant, underscoring their impaired memory retention. These findings suggest that PHPD5 treatment effectively restored the learning and memory abilities of Tau609 mice to levels like those of healthy WT mice. The treated mice's ability to improve their performance during training and retain the memory of the platform's location highlights the peptide’s potential in addressing cognitive deficits caused by tau pathology.

These results align with previous observations that PHPD5 stabilizes tau and facilitates dynamin availability for vesicle recycling, thereby restoring synaptic communication. By mitigating the effects of tau tangles and neuronal dysfunction, the peptide appears to directly address the mechanisms underlying learning and memory impairments. The success of PHPD5 in this experimental setup has far-reaching implications for Alzheimer’s disease research and treatment development.

Future studies should focus on investigating the long-term effects of sustained treatment with PHPD5, conducting human trials to evaluate its safety and efficacy, and exploring its potential as part of combination therapies targeting both tau and beta-amyloid. Additionally, researchers should assess whether PHPD5 could benefit other tau-related neurodegenerative diseases, such as frontotemporal dementia or progressive supranuclear palsy. If the success seen in animal models translates to humans, PHPD5 could represent a breakthrough in Alzheimer’s treatment, offering hope for millions affected by the disease.

A new target for Alzheimer’s treatment?

These are early findings in a new target area for Alzheimer’s treatment, but the study has shown that, in mice, drugs administered intranasally can cross the blood-brain barrier to reach the part of the brain most affected by Alzheimer’s. It has also shown that the synthetic peptide can reverse some of the damage caused by tau in mice genetically engineered to develop Alzheimer’s-like pathophysiology. The research on PHDP5 and its potential to reverse cognitive decline in Alzheimer’s is very encouraging and represents a significant advancement in the search for effective treatments. This could pave the way for new treatments that might prevent or significantly delay the progression of cognitive symptoms in Alzheimer’s.

References:

[Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789. PMID: 33302541; PMCID: PMC7764106.](https://doi.org/10.3390/molecules25245789 "Comprehensive Review on Alzheimer’s Disease: Causes and Treatment")

[Bondi MW, Edmonds EC, Salmon DP. Alzheimer's Disease: Past, Present, and Future. J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X. PMID: 29198280; PMCID: PMC5830188.](https://doi.org/10.1017/S135561771700100X "Alzheimer’s Disease: Past, Present, and Future")

[Ana R. Monteiro, Daniel J. Barbosa, Fernando Remião, Renata Silva, Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs, Biochemical Pharmacology, Volume 211, 2023, 115522, ISSN 0006-2952, https://doi.org/10.1016/j.bcp.2023.115522.](https://doi.org/10.1016/j.bcp.2023.115522 "Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs")

[Chia-Jung Chang, Zacharie Taoufiq, Hiroshi Yamada, Kohji Takei, Takami Tomiyama, Tomohiro Umeda, Tetsuya Hori, Tomoyuki Takahashi, The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice, Brain Research, Volume 1838, 2024, 148987, ISSN 0006-8993, https://doi.org/10.1016/j.brainres.2024.148987.](https://doi.org/10.1016/j.brainres.2024.148987 "The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer’s disease model mice")

Product available for research use only.

[]( "p21 5mg")[]( "N-Acetyl Selank Amidate 10mg")

Posted in: Alzheimer's Research PHDP5

Be the first to know

Receive all the latest information on events, sales, & offers.

Terms and Conditions of Purchase

Your Use of Our Web Site

Unless specified otherwise, your use of this Web Site is governed by this Terms and Conditions of Use Agreement and the Privacy Policy, which is incorporated herein by this reference. In using this Web Site, you are prohibited from modifying, distributing, transmitting, reproducing, publishing, licensing, transferring, or selling any information, products or services obtained or viewed on this Web Site. However, you may display, download, or print hard copies of any material contained on this Web Site for your own personal, non-commercial use as long as you do not modify the content or delete any copyright, trademark, or other proprietary notice. Any other use of the information contained on this Web Site is prohibited without our express written consent.

All ACH/e-Check payments will be made payable to:

P-Sciences, Inc.

Each time I (the customer) places an ACH/e-Check order by clicking the "Place Order" button, I am authorizing to initiate a single ACH/electronic debit to my account in the amount of my order from the bank account information provided on the date of my order. I agree that ACH transactions I authorize comply with all applicable law. Payments made after 11 P.M. pacific time will be applied as of the next business day. To complete the payment process, click the “Place Order” button. Once payment is authorized, there cannot be any changes or corrections. It is recommended that you print a copy of this authorization and maintain it for your records.

Use of Information

This Web site provides information that, while useful, must not be used as a substitute for the advice of your own advisors. Information available from this Web Site is not intended to be used to diagnose any medical condition or disease. Products on this website are sold for laboratory research purposes only.

reserves the right to correct any inaccuracies or typographical errors in the information posted on this Web Site, and shall have no liability for such errors. Information may be changed or updated without notice and prices and availability of goods and services are subject to change without notice.

DISCLAIMER:

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

The products we offer are intended for IN-VITRO LABORATORY RESEARCH USE ONLY-- NOT FOR HUMAN USE.

In purchasing any of these items, the customer acknowledges that there are risks involved with consumption or distribution of these products.

These chemicals are NOT intended to use as food additives, drugs, household chemicals or other inappropriate applications.

The listing of a material on this site does not constitute a license to its use in infringement of any patent.

All of the products will be handled only by qualified and properly trained RESEARCH or LABORATORY professionals only.

Due to the nature of these products ALL SALES ARE FINAL. WE CANNOT ACCEPT RETURNS. ALL SALES ARE FINAL.

All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following:

Use of the products and more specifically In-vitro Research use of the products.

Your specific countries Government regulations regarding the use of and exposure to all products.

The health and safety hazards associated with the handling of the products they purchase.

The necessity of adequately warning of the health and safety hazards associated with any products.

reserves the right to limit and/or deny sales of products to any unqualified individuals. All customers MUST be at least 21 years of age to purchase our products. IN NO CIRCUMSTANCE SHALL BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, WHETHER PURCHASER'S CLAIM IN CONTRACT, NEGLIGENCE, STRICT LIABILITY OR OTHERWISE. IN DIRECT CONSIDERATION OF APPROVING THE SALE OF ANY PRODUCT TO THE PURCHASER, THE PURCHASER AGREES TO INDEMNIFY AND HOLD US HARMLESS FROM ALL CLAIMS, EXPENSES, LOSSES AND LIABILITY OF ANY TYPE ARISING OUT OF THE PURCHASER'S HANDLING, POSSESSION, AND/OR USE OF THE PRODUCT, WHETHER USED ALONE OR IN COMBINATION WITH ANY SUBSTANCE. ANY SALE WOULD BE DENIED OTHERWISE.

PRODUCT USE:

products are intended for laboratory IN-VITRO RESEARCH PURPOSES ONLY-- NOT FOR HUMAN USE and are not to be used for any other purposes, including but not limited to food and/or drugs, medical devices, vitro diagnostic purpose, or for commercial purposes. The purchaser agrees that the products have not been sterilized or tested by for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. The purchaser expressly represents and warrants to that the purchaser will properly test, use, manufacture and market any products purchased from and/or materials produced with products purchased from in accordance with the practices of a reliable person who is experienced in the field and in strict compliance with all applicable laws and regulations, now and hereinafter enacted. The purchaser further warrants that any material produced with any product shall not be adulterated or misbranded within the meaning of the Federal Food, Drug, and Cosmetic Act and shall not be materials which may not, under Sections 404, 505, or 512 of the Act, be introduced into interstate commerce.

The purchaser realizes that, since products are, unless otherwise stated, intended solely for in-vitro research purposes, they may not be on the Toxic Substances Control Act (TSCA) inventory listing. The purchaser assumes responsibility to assure that the products purchased from are approved for use under TSCA, if applicable.

Purchaser has the responsibility to verify the hazards and to conduct any further research necessary to learn the hazards involved in using products purchased from Purchaser agrees to comply with instructions, if any, furnished by relating to the use of the products and not misuse the products in any manner. No products purchased from shall, unless otherwise stated, be considered to be foods, drugs, or medical devices.

ALL products and services offered are for IN-VITRO RESEARCH purposes ONLY and are NOT TO BE INGESTED or CONSUMED IN ANY MANNER.

ALL PRODUCTS SOLD BY THE ARE NOT TO BE USED FOR PERSONAL USE OR FOR THE TREATMENT OF ANY MEDICAL CONDITION OR DISEASE.

Under NO circumstances shall/ should ANY of these materials be used for recreational purposes nor human consumption of any kind.

is NOT liable for ANY damages that may be caused by negligence, abuse, or ANY other unforeseen matter.

All items sold are legal for sale for IN-VITRO RESEARCH PURPOSES SPECIFICALLY within the USA.

Trade-Marks and Other Intellectual Property Rights

"" is a registered trademark of

All text, graphics, user interfaces, visual interfaces, photographs, trademarks, logos, sounds, music, artwork and computer code (collectively, "Content"), including but not limited to the design, structure, selection, coordination, expression, "look and feel" and arrangement of such Content, contained on this Web Site is owned, controlled or licensed by or to and is protected by copyright, patent and trademark laws, and various other intellectual property rights and unfair competition laws.

Except as expressly provided in this Terms and Conditions of Use Agreement, no part of this Web Site and no Content may be copied, reproduced, republished, uploaded, posted, publicly displayed, encoded, translated, transmitted or distributed in any way (including "mirroring") to any other computer, server, web site or other medium for publication or distribution or for any commercial enterprise, without express prior written consent.

Indemnity

You hereby agree to indemnify and hold and our subsidiaries, affiliates, officers, directors, agents, co-branders, partners, and employees harmless from any claim or demand, including reasonable attorney's fees, made by any third party due to or arising out of your use of the content on this Web Site, or any content you submit, post, or transmit through this Web Site, your use of this Web Site, your connection to this Web site, your violation of this Terms and Conditions of Use Agreement, or your violation of any rights of another.

Links/Software

Links from or to websites outside this Web Site are meant for convenience only. does not review, endorse, approve or control, and is not responsible for any sites linked from or to this Web Site, the content of those sites, the third parties named therein, or their products or services. Linking to any other site is at your sole risk and will not be responsible or liable for any damages in connection with linking. disclaims all warranties, express and implied as to the accuracy, validity and legality of any materials or information found on those sites. Links to downloadable software sites are for convenience only and is not responsible or liable for any difficulties or consequences associated with downloading the software. Use of any downloaded software is governed by the terms of the license agreement, if any, which accompanies or is provided with the software.

Availability of Our Web Site

This Web Site is generally available to users Twenty-four (24) hours per day, Seven (7) days per week, Three Hundred Sixty-five (365) days per year. However, retains the right to make our Web Site unavailable at any time, for any reason, and for any length of time. By using this Web Site you agree that will not be liable for any damage arising out of or related to any such interruption, suspension, or termination of this Web Site and/or the services or products contained therein. Upon acceptance of these terms and conditions of use authorizes you to view the Content on the Web Site solely for your personal use. The material on the Web Site is intended solely for individuals enquiring about products or services. If you are not accessing the Web Site for such purposes, you may not use the Web Site. For certainty, use by non-individuals or the agents, attorneys or representatives of non-individuals is prohibited.

**Information You Provide

Our collection and/or use of any information you provide while using or visiting this Web Site is governed by the Privacy Policy and this Terms and Conditions of Use Agreement. By using this Web Site you grant us the rights contained therein. In using this Web Site you may not upload, distribute, or otherwise publish on this Web Site any information which may be viewed as obscene, defamatory, libelous, threatening, abusive, illegal, an invasion of privacy rights, or otherwise objectionable, or may constitute or encourage a violation of any law.

Except for that individually-identifiable information collected from you in accordance with our Privacy Policy, all comments, remarks, suggestions, ideas or other information communicated will become the exclusive property of and you grant to a royalty-free, perpetual, irrevocable, world-wide, non-exclusive license to use or reproduce the same. is free to copy, disclose, distribute or analyze any such information for any and all purposes and are in no way obligated to compensate you for any such information.

Disclaimer of Warranties

PROVIDES CONTENT ON THIS WEB SITE AS A SERVICE TO YOU, OUR CUSTOMER. THIS WEB SITE CANNOT AND DOES NOT, CONTAIN INFORMATION ABOUT ALL APPLICATIONS FOR PRODUCTS SOLD. IT MAY NOT CONTAIN ALL INFORMATION THAT IS APPLICABLE TO YOUR PERSONAL CIRCUMSTANCES OR YOUR USE OF PRODUCTS SOLD. THE CONTENT OF THIS WEB SITE, THE WEB SITE SERVER THAT MAKES IT AVAILABLE, AND THE SERVICES AND PRODUCTS PROVIDES ON THIS WEB SITE, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTY OF ANY KIND, WHETHER EXPRESS, IMPLIED OR STATUTORY. EXPRESSLY DISCLAIMS LIABILITY FOR TECHNICAL FAILURES (INCLUDING HARDWARE OR SOFTWARE FAILURES), INCOMPLETE, SCRAMBLED OR DELAYED COMPUTER TRANSMISSIONS, AND/OR TECHNICAL INACCURACIES, AS WELL AS UNAUTHORIZED ACCESS OF USER TRANSMISSIONS BY THIRD PARTIES. FURTHER, DOES NOT REPRESENT OR WARRANT THAT NO VIRUSES OR OTHER CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE TRANSMITTED, OR THAT NO DAMAGE WILL OCCUR TO YOUR COMPUTER SYSTEM. YOU HAVE SOLE RESPONSIBILITY FOR ADEQUATE PROTECTION AND BACKUP OF DATA AND/OR EQUIPMENT AND TO TAKE ALL PRECAUTIONS TO SCAN FOR COMPUTER VIRUSES OR OTHER DESTRUCTIVE PROPERTIES. BY YOUR USE OF THIS WEB SITE, YOU ACKNOWLEDGE THAT SUCH USE IS AT YOUR SOLE RISK, INCLUDING RESPONSIBILITY FOR ALL COSTS ASSOCIATED WITH ALL NECESSARY SERVICING OR REPAIRS OF ANY EQUIPMENT YOU USE IN CONNECTION WITH THIS WEB SITE.

TO THE FULL EXTENT NOT PRECLUDED BY APPLICABLE LAW THEIR MEDICAL ADVISORS, SUPPLIERS, CONSULTANTS, DIRECTORS AND EMPLOYEES DISCLAIM AND EXCLUDE ALL WARRANTIES WITH RESPECT TO ALL CONTENT, EXPRESS, IMPLIED OR STATUTORY. THIS DISCLAIMER INCLUDES, BUT IS NOT LIMITED TO, ANY AND ALL WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. DOES NOT WARRANT THE CONTENT TO BE ACCURATE, COMPLETE OR CURRENT. DOES NOT WARRANT THAT THIS WEB SITE WILL OPERATE WITHOUT ERROR, THAT DEFECTS WILL BE CORRECTED OR THAT THIS WEB SITE OR THE WEB SITE SERVER MAKING IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. PRICE AND AVAILABILITY CONTENT, AS WELL AS OTHER CONTENT CONTAINED IN THIS WEB SITE OR ACCESSIBLE THEREFROM, IS SUBJECT TO CHANGE WITHOUT NOTICE.

YOU ACKNOWLEDGE AND AGREE THAT DOES NOT ENDORSE THE CONTENT OF ANY SITE ACCESSED VIA LINKS OR OTHER MEANS FROM THIS WEB SITE AND IT IS NOT RESPONSIBLE OR LIABLE FOR SUCH CONTENT EVEN THOUGH IT MAY BE UNLAWFUL, HARASSING, LIBELOUS, PRIVACY INVADING, ABUSIVE, THREATENING, HARMFUL, OBSCENE, OR OTHERWISE OBJECTIONABLE, OR THAT IT INFRINGES OR MAY INFRINGE THE INTELLECTUAL PROPERTY OR OTHER RIGHTS OF ANOTHER PERSON.

THIS WEB SITE INCLUDES CONTENT PROVIDED BY THIRD PARTIES AND YOU, OUR CUSTOMER. IS A DISTRIBUTOR OF SUCH CONTENT AND NOT ITS PUBLISHER. EDITORIAL CONTROL OF SUCH CONTENT IS THE SAME AS THAT OF A PUBLIC LIBRARY OR NEWSSTAND. THIRD PARTY SUPPLIERS MAY EXPRESS CERTAIN OPINIONS OR PROVIDE CERTAIN INFORMATION AND OFFERS. MAKES NO WARRANTIES AS TO THE COMPLETENESS, ACCURACY, TIMELINESS, OR RELIABILITY OF INFORMATION OR OFFERS SUPPLIED BY THIRD PARTIES. DOES NOT GUARANTEE OR WARRANT THE PERFORMANCE OF ANY THIRD PARTY, INCLUDING ANY SUCH THIRD PARTY’S CONFORMANCE TO ANY LAW, RULE, REGULATION OR POLICY.

DOES NOT WARRANT THAT INFORMATION, SERVICES, AND PRODUCTS CONTAINED IN THIS WEB SITE WILL SATISFY YOUR REQUIREMENTS OR THAT THEY ARE ERROR OR DEFECT-FREE. BEFORE USING ANY PRODUCT YOU SHOULD CONFIRM ANY INFORMATION OF IMPORTANCE TO YOU ON THE PRODUCT PACKAGING. YOU ASSUME RESPONSIBILITY FOR THE ACCURACY, APPROPRIATENESS AND LEGALITY OF ANY INFORMATION YOU SUPPLY

AS PARTIAL CONSIDERATION FOR YOUR ACCESS TO THIS WEB SITE AND USE OF ITS CONTENT, YOU AGREE THAT IS NOT LIABLE TO YOU IN ANY MANNER WHATSOEVER FOR DECISIONS YOU MAY MAKE OR YOUR ACTIONS OR NON-ACTIONS IN RELIANCE UPON THE CONTENT. YOU ALSO AGREE THAT THE AGGREGATE LIABILITY OF ARISING FROM OR RELATED TO YOUR USE AND ACCESS REGARDLESS OF THE FORM OF ACTION OR CLAIM (FOR EXAMPLE, CONTRACT, WARRANTY, TORT, NEGLIGENCE, STRICT LIABILITY, PROFESSIONAL MALPRACTICE, FRAUD, OR OTHER BASES FOR CLAIMS), IS LIMITED TO THE PURCHASE PRICE OF ANY ITEMS YOU PURCHASED FROM IN THE APPLICABLE TRANSACTION. SHALL NOT IN ANY CASE BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES EVEN IF HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS IS A COMPREHENSIVE LIMITATION OF LIABILITY THAT APPLIES TO ALL LOSES AND DAMAGES OF ANY KIND. IF YOU ARE DISSATISFIED WITH THIS WEB SITE OR ITS CONTENT (INCLUDING TERMS OF USE), YOUR SOLE EXCLUSIVE REMEDY IS TO DISCONTINUE USING THIS WEB SITE. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, SUCH LIMITATION MAY NOT BE APPLICABLE TO YOU.

Your Agreement to Abide by All Applicable Laws

By using this Web Site you agree to comply with any and all local, state, or federal laws, statutes, and regulations that relate in any manner to the use of this Web Site and the associated services or products contained thereon.

Relationship between and Users.

and users of our Site are independent contractors, and no agency, partnership, employment or other relationship is created or is intended to be created by the use of our Web Site.

Governing Law and Jurisdiction

This Web Site (excluding linked sites, if any) is administered and controlled by and its affiliates, subsidiaries, officers, directors, employees or agents from its offices in the accordance with the laws of Nevis. You agree that this Terms and Conditions of Use Agreement and this Web Site will be governed by and construed in accordance Nevis law without giving effect to any principles of conflicts of laws. You access this Web Site and/or associated services of at your own risk, and remain responsible for complying with the laws of the jurisdiction within which you are located.

Prices; Payment Terms; Interest

The prices for the products and services on this Web Site are quoted, for convenience, in United States dollars and shall be as set forth in this Web Site as at the time of acceptance of an order by Prices for Products shall be subject to change without any further notice. Credit terms are within sole discretion, and unless otherwise specified in invoice, payment must be received by prior to acceptance of an order.

Consequences

reserves the right to suspend or terminate your account if you violate the Terms of Use Agreement. If your violation causes harm to others, you agree to indemnify and hold harmless from and against any and all loss, damage, or expense. If any dispute arises between us regarding this Agreement or your use of this Web Site, it shall be resolved through good faith negotiations between the parties.

Entire Agreement

These Terms and Conditions and any terms incorporated or referred to herein constitute the entire agreement between and you relating to your use of this Web Site and the subject matter hereof, and supersede any prior understandings or agreements (whether electronic, oral or written) regarding the subject matter, and may not be amended or modified except in writing, or by making such amendments or modifications in accordance with this Terms and Conditions of Use Agreement.

Severability

If any part of this Terms and Conditions of Use Agreement is deemed or determined to be unenforceable, then such part shall be eliminated or limited to the minimum extent necessary. The remainder of this Terms and Conditions of Use Agreement, including any revised portion, shall remain and be in full force and effect. This Terms and Conditions of Use Agreement are the entire agreement between us governing your use of this Web Site.

Headings

The headings contained in this Terms and Conditions of Use Agreement and the Privacy Policy are for reference only.

Force Majeure

shall not be liable for any delay or failure in performance caused by circumstances beyond its reasonable control, including, without limitation, delays due to backorders of requested products, mail delays, customs delays or lost shipments. shall not be responsible to notify the Customer in the event of such delays. The Customer shall be solely responsible to make other arrangements to purchase alternative products and any costs incurred in connection with such purchases.

Thank you again for visiting the Web Site.

Complete Agreement

Except as expressly provided in a particular "legal notice" on this Site, these Terms and Conditions constitute the entire agreement between you and this Site with respect to the use of this Site, and Content. By clicking “I agree” when placing your order, you agree with ALL OF OUR TERMS and CONDITIONS as stated above as well as our Shipping and refunds Policy.

Thank you for your cooperation.

Terms and Conditions of Purchase

Your Use of Our Web Site

Use of Information

DISCLAIMER:

Shipping address will be selected within Apple Pay. Any address entered in checkout will not be used.